These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 33862)

  • 1. Initial experience with a new long-acting beta-blocker, nadolol, in hypertensive patients.
    Hitzenberger G
    J Int Med Res; 1979; 7(1):33-8. PubMed ID: 33862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA
    J Fam Pract; 1980 Aug; 11(2):199-205. PubMed ID: 6106039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of essential hypertension using nadolol and hydrochlorothiazide combined.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    Br J Clin Pharmacol; 1979; 7 Suppl 2(Suppl 2):199S-203S. PubMed ID: 37875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-ranging study of the new beta-adrenergic antagonist nadolol in the treatment of essential hypertension.
    Frithz G
    Curr Med Res Opin; 1978; 5(5):383-7. PubMed ID: 26519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of essential hypertension with Nadolol and Hydrochlorothiazide: a two-year follow-up.
    El-Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1982; 10(2):87-91. PubMed ID: 6802691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nadolol (Corgard) - a new beta-blocker.
    Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
    [No Abstract]   [Full Text] [Related]  

  • 7. Preserved renal perfusion during treatment of essential hypertension with the beta blocker nadolol.
    O'Connor DT; Barg AP; Duchin KL
    J Clin Pharmacol; 1982 Apr; 22(4):187-95. PubMed ID: 6124557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nadolol in treatment of hypertension.
    Volicer L; Liang CS; Gavras H; Tifft CP; Kershaw GR; Gavras I; Griffith DL; Vukovitch R; Brunner HR
    J Clin Pharmacol; 1979; 19(2-3):137-47. PubMed ID: 33998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term experience with nadolol in treatment of hypertension and angina pectoris.
    Alexander JC; Christie MH; Vernam KA; Fand RS; Shafer WB
    Am Heart J; 1984 Oct; 108(4 Pt 2):1136-40. PubMed ID: 6148874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS; Fand RS
    Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Field trial with a new betablocker (Solgol)].
    Piergies A; Schimert G
    MMW Munch Med Wochenschr; 1980 Oct; 122(42):1473-6. PubMed ID: 6110182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled trial on three beta-blockers: antihypertensive efficacy and effect on the hypertensive heart disease.
    Pupita F; Ansuini R; Belogi M; Pupita G; Gaggi S
    Int J Clin Pharmacol Res; 1985; 5(6):439-45. PubMed ID: 2869001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term evaluation of nadolol, a long-acting beta-adrenergic blocking agent, in the management of hypertension in general practice.
    O'Callaghan EG
    Br J Clin Pract; 1982 Jun; 36(6):235-9. PubMed ID: 6128994
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of nadolol to determine its effect on ambulatory blood pressure over 24 hours, and during exercise testing.
    Hornung RS; Gould BA; Kieso H; Raftery EB
    Br J Clin Pharmacol; 1982 Jul; 14(1):83-8. PubMed ID: 6125200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nadolol in hypertensive patients maintained on long-term hemodialysis.
    Michaels RS; Duchin KL; Akbar S; Meister J; Levin NW
    Am Heart J; 1984 Oct; 108(4 Pt 2):1091-4. PubMed ID: 6148869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and cardiohemodynamic effects of the new long-acting beta-blocker tobanum].
    Ol'binskaia LI; Vartanova OA
    Kardiologiia; 1986 Feb; 26(2):48-51. PubMed ID: 2422430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with carvedilol.
    Moser M
    J Hum Hypertens; 1993 Feb; 7 Suppl 1():S16-20. PubMed ID: 8098064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA
    Br J Clin Pract; 1980 Jul; 34(7):211-21. PubMed ID: 6107120
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.